Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04536090 |
|
Recruitment Status :
Not yet recruiting
First Posted : September 2, 2020
Last Update Posted : August 23, 2021
|
Sponsor:
Institut de Recherches Cliniques de Montreal
Collaborators:
Pharmascience Inc.
SCiAN Services, Inc.
Quercis Pharma AG
Information provided by (Responsible Party):
Institut de Recherches Cliniques de Montreal
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | December 2022 |
| Estimated Study Completion Date : | June 2023 |